Orthocell advances toward U.S. launch of nerve repair device Remplir™
Proactive Investor UK - 01-Dec-2024Clinical success and FDA submission mark pivotal steps in redefining nerve regeneration solutions
Join the club for FREE to access the whole archive and other member benefits.
Clinical success and FDA submission mark pivotal steps in redefining nerve regeneration solutions
New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
Experts discuss on the ethics and feasibility of body transplants in the near future
This could potentially revolutionize treatment for severe conditions
Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts
No resources found!
No blog posts found!